BOT 4.62% 34.0¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-449

  1. 4,390 Posts.
    lightbulb Created with Sketch. 1359
    The end game is the sale to Pfizer and friends for mine.

    They don't need to release feel good videos. They know their IP is first in line and worth billions of dollars.

    Vinnie and Matt will be on the phone. The likes of GW will put a light on this even more so.

    I'd be shocked if the pharma's didn't contact them already.

    It was Cowan and their American connections who begged our little company for stock prior to phase 2 acne (after they saw the antibiotic properties of what BOT has).

    Raising $35 mill US was a piece of cake and they wanted more. Matt limited them at the time from memory.

    Can only imagine what they are after now after the de-risked results.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.